GPT and hepatocellular carcinoma: Conversely, a negative correlation was found with transaminases (median (IQR) ALT: 35 (30–71) vs. 83 (48–108) U/L, p = 0.004 and median (IQR) AST: 39 (30–71) vs. 84 (59–119) U/L, p = 0.01), suggesting that the involvement of these mutations in HCC onset may not be mediated by enhancing necroinflammation.